Making Improvements in Treating Kidney Disease

Video

In the past there were few effective treatment options for serious conditions such as hepatitis C and lupus. However, recent scientific advances offer physicians and patients greatly improved options for effective management of these conditions, with fewer adverse events.

In the past there were few effective treatment options for serious conditions such as hepatitis C and lupus. However, recent scientific advances offer physicians and patients greatly improved options for effective management of these conditions, with fewer adverse events.

At Kidney Week 2014, Jai Radhakrishnan, MD, MS, MRCP, FASN, discussed some of the progress made in treating patients with these diseases and noted that new medication options mean that these conditions have become more managable in recent years.

Recent Videos
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Signs and Symptoms of Connective Tissue Disease
© 2024 MJH Life Sciences

All rights reserved.